Key Record Dates
ClinicalTrials.gov Identifier: | NCT02170727 |
---|---|
Brief Title: | A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 (UNITY 4) |
First Submitted : | June 20, 2014 |
First Submitted that Met QC Criteria : | June 20, 2014 |
First Posted : | June 23, 2014 (Estimate) |
Results First Submitted : | March 22, 2019 |
Results First Submitted that Met QC Criteria : | July 9, 2019 |
Results First Posted : | August 16, 2019 |
Certification/Extension First Submitted : | March 22, 2017 |
Certification/Extension First Submitted that Met QC Criteria : | March 22, 2017 |
Certification/Extension First Posted : | March 23, 2017 |
Last Update Submitted that Met QC Criteria : | October 27, 2020 |
Last Update Posted : | October 29, 2020 |